Award

Purchase of Nanobodies and epitope mapping for grant funded project

MHRA

This public procurement record has 1 release in its history.

Award

09 Dec 2025 at 08:34

Summary of the contracting process

The Medicines and Healthcare products Regulatory Agency (MHRA), a central government public authority based in London, United Kingdom, has completed the procurement process for a project titled "Purchase of Nanobodies and epitope mapping for grant funded project." This contract, worth €80,000 with a gross amount of €96,000, covers laboratory services, laboratory reagents, and medical analysis services crucial to the healthcare and biopharmaceutical industry. The procurement method adopted was direct, without competition, due to the time-sensitive nature and specific expertise required for the project. The contract was awarded to Proteogenix SAS, a large supplier based in Schiltigheim, France. The document was officially signed on 10th November 2025, and the contract period is from 11th November 2025 to 10th November 2026.

This tender presents significant opportunities for businesses specialising in producing laboratory reagents and advanced medical analysis services. Firms with capabilities in protein expression, especially those focusing on nanobody sequences, stand to gain substantially by positioning themselves as key suppliers in similar direct award contexts. The specificity and time constraints outlined in this contract highlight an environment in which nimble, experienced businesses in niche biopharmaceutical markets can excel and expand their market reach, particularly in serving public authorities engaged in high-priority, grant-financed projects.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Purchase of Nanobodies and epitope mapping for grant funded project

Notice Description

The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA's prior in house validation of nanobody products made by this supplier , makes this supplier in our view the only provider that can realistically meet our request within the allocated timelines. Protein production can be outsourced from several commercial entities, but the trade for companies that have relevant and ample experience in nanobody expression, at small scale, in a cost-effective and time-saving manner to fulfil our request is limited. Further, the timeline to complete the objectives of the project with the awarded grant finance translates into the inability to search, outsource, trial and validate the suitability of nanobodies produced by other suppliers unknown to MHRA, significantly narrowing feasible possibilities.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05f155
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/080869-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Below threshold - without competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

71 - Architectural, construction, engineering and inspection services

85 - Health and social work services


CPV Codes

33696500 - Laboratory reagents

71900000 - Laboratory services

85148000 - Medical analysis services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£80,000 Under £100K

Notice Dates

Publication Date
9 Dec 20252 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
10 Nov 20253 months ago
Contract Period
11 Nov 2025 - 10 Nov 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
MHRA
Contact Name
Aun Bhatti
Contact Email
purchasing@mhra.gov.uk
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified

Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

PROTEOGENIX

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-05f155-2025-12-09T08:34:42Z",
    "date": "2025-12-09T08:34:42Z",
    "ocid": "ocds-h6vhtk-05f155",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PJLJ-9824-VXPG",
            "name": "MHRA",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PJLJ-9824-VXPG"
            },
            "address": {
                "streetAddress": "10 South Colonnade, Canary Wharf",
                "locality": "London",
                "postalCode": "E14 4PU",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "name": "Aun Bhatti",
                "email": "purchasing@mhra.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-168604",
            "name": "Proteogenix SAS",
            "address": {
                "streetAddress": "19 rue de La Haye",
                "locality": "Schiltigheim",
                "postalCode": "67300",
                "country": "FR",
                "countryName": "France",
                "region": "FR"
            },
            "contactPoint": {
                "email": "inquiry-mabs@proteogenix.fr"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "vcse": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PJLJ-9824-VXPG",
        "name": "MHRA"
    },
    "tender": {
        "id": "C395306",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Purchase of Nanobodies and epitope mapping for grant funded project",
        "description": "The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA's prior in house validation of nanobody products made by this supplier , makes this supplier in our view the only provider that can realistically meet our request within the allocated timelines. Protein production can be outsourced from several commercial entities, but the trade for companies that have relevant and ample experience in nanobody expression, at small scale, in a cost-effective and time-saving manner to fulfil our request is limited. Further, the timeline to complete the objectives of the project with the awarded grant finance translates into the inability to search, outsource, trial and validate the suitability of nanobodies produced by other suppliers unknown to MHRA, significantly narrowing feasible possibilities.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Below threshold - without competition",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "status": "active",
            "mainProcurementCategory": "goods",
            "suppliers": [
                {
                    "id": "GB-FTS-168604",
                    "name": "Proteogenix SAS"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "71900000",
                            "description": "Laboratory services"
                        },
                        {
                            "scheme": "CPV",
                            "id": "33696500",
                            "description": "Laboratory reagents"
                        },
                        {
                            "scheme": "CPV",
                            "id": "85148000",
                            "description": "Medical analysis services"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "1",
            "awardID": "1",
            "title": "Purchase of Nanobodies and epitope mapping for grant funded project",
            "status": "active",
            "period": {
                "startDate": "2025-11-11T00:00:00Z",
                "endDate": "2026-11-10T23:59:59Z"
            },
            "value": {
                "amountGross": 96000,
                "amount": 80000,
                "currency": "EUR"
            },
            "aboveThreshold": false,
            "dateSigned": "2025-11-10T00:00:00Z",
            "documents": [
                {
                    "id": "080869-2025",
                    "documentType": "contractNotice",
                    "noticeType": "UK7",
                    "description": "Contract details notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/080869-2025",
                    "datePublished": "2025-12-09T08:34:42Z",
                    "format": "text/html"
                }
            ]
        }
    ],
    "language": "en"
}